Natixis Bleichroeder Starts Quest Diagnostics (DGX) at Buy
Get Alerts DGX Hot Sheet
Price: $244.11 +0.97%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 19
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 19
Join SI Premium – FREE
Natixis Bleichroeder initiates coverage on Quest Diagnostics (NYSE: DGX) with a Buy. PT $59.00.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $50.36 yesterday.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $50.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WHOOP Makes Advanced Labs Available Without a Wearable Membership
- William Blair Starts Surrozen Inc. (SRZN) at Outperform
- JPMorgan Starts UMB Financial (UMBF) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Natixis BleichroederSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share